Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Approved

Current status date:

2020-03-17

Product name:

RHEUMOCAM 15 MG/ML ORAL SUSPENSION

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02497263

Product Monograph/Veterinary Labelling:

Date: 2020-09-02 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED
Dublin Road
Loughrea
Co. Galway
Ireland

Class: 

Veterinary

Species:

Cattle

Dosage form(s):

Suspension

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

Not Applicable

Anatomical Therapeutic Chemical (ATC): See footnote 4

Not Applicable

Active ingredient group (AIG) number:See footnote 5

0131676004

List of active ingredient(s)
Active ingredient(s) Strength
MELOXICAM 15 MG / ML

Application information

Related information

Contact us

Version 3.7.4
Date modified: